All Stories

  1. Quetiapine Abuse Fourteen Years Later: Where Are We Now? A Systematic Review

    Article • Substance Use & Misuse, October 2019, Taylor & Francis

    Dr Georgios D. Kotzalidis, Dr Duccio Papanti

  2. The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review

    Article • Expert Review of Neurotherapeutics, September 2019, Taylor & Francis

    John Corkery, Amira Guirguis, Dr Duccio Papanti

  3. Cannabis; Epidemiological, Neurobiological and Psychopathological Issues: An Update

    Article • CNS & Neurological Disorders - Drug Targets, August 2017, Bentham Science Publishers

    Dr Duccio Papanti, John Corkery, PhD Cristina Cadoni

  4. Is there a Teratogenicity Risk Associated with Cannabis and Synthetic Cannabimimetics’ (‘Spice’) Intake?

    Article • CNS & Neurological Disorders - Drug Targets, August 2017, Bentham Science Publishers

    Dr Duccio Papanti, John Corkery, PhD Cristina Cadoni

  5. Is there a potential of misuse for Magnolia officinalis compounds/metabolites?

    Article • Human Psychopharmacology Clinical and Experimental, May 2017, Wiley

    Dr Duccio Papanti, John Corkery

  6. An insight into the deep web; why it matters for addiction psychiatry?

    Article • Human Psychopharmacology Clinical and Experimental, May 2017, Wiley

    Dr Duccio Papanti, John Corkery

  7. From concept(ion) to life after death/the grave: The ‘natural’ history and life cycle(s) of novel psychoactive substances (NPS)

    Article • Human Psychopharmacology Clinical and Experimental, May 2017, Wiley

    Dr Duccio Papanti, John Corkery

  8. “Noids” in a nutshell: everything you (don’t) want to know about synthetic cannabimimetics

    Article • Advances in Dual Diagnosis, August 2014, Emerald

    Dr Duccio Papanti